Vietnam Boosts RSV Prevention for Infants with OB/GYN and Pediatric Expert Collaboration

Vietnam is facing a pressing issue in protecting the health of infants and young children, with a focus on strategies against Respiratory Syncytial Virus (RSV) infections. On July 26, 2024, in Hanoi, the Vietnam Association of Obstetrics and Gynecology, with scientific support from Pfizer Vietnam, organized a symposium titled "Maternal Care Strategy: Proactive Mothers - Protected Children." The event brought together leading specialists in obstetrics, gynecology, and pediatrics to engage in active discussions on RSV prevention measures for infants and young children. The symposium highlighted the dangers of RSV, particularly its prevalence during the winter season, and underscored the effectiveness of vaccination in reducing the burden of diseases caused by this virus. Experts also emphasized the importance of preventive measures against RSV infection for high-risk infant groups, agreeing that proactive measures from an early stage are key to safeguarding children's health. Under Vietnam's single-party system, public health policies are driven by the state, with the promotion of national health recognized as a significant social agenda. This expert meeting can be seen as part of these national health strategies, seeking concrete measures based on the latest medical knowledge. As Vietnam continues its economic growth, its healthcare infrastructure is also developing. However, in terms of infectious disease control, strengthening preventive healthcare, with the cooperation of international pharmaceutical companies, is crucial.